Wiedermann G
Fortschr Med. 1984 Mar 29;102(12):333-5.
Pneumococcal vaccination may be recommended for certain risk groups according to Landesman and Schiffman such as people with heart and pulmonary diseases, sickle cell anemia, condition after splenectomy, M. Hodgkin, multiple myeloma, immune suppression. The vaccination is also indicated in elderly people (above 60 years). 14 oder 17-valent polysaccharide-vaccines are available which are well tolerated although mild side effects are possible. The immunogenicity is good in young as well as elderly people, antibody levels as high as 250-300 ng antibody nitrogen/ml are protective according to Landesman and Schiffman. A field trial performed in elderly people revealed a preferential influence on the case-fatality rate. The vaccination shall not be repeated within 4-5 years because of possible local reactions due to local antigen-antibody union.
根据兰德斯曼和希夫曼的观点,对于某些风险群体可能建议接种肺炎球菌疫苗,例如患有心脏和肺部疾病、镰状细胞贫血、脾切除术后、霍奇金淋巴瘤、多发性骨髓瘤、免疫抑制的人群。老年人(60岁以上)也适合接种。有14价或17价多糖疫苗可供使用,虽然可能会有轻微副作用,但耐受性良好。疫苗在年轻人和老年人中免疫原性都很好,根据兰德斯曼和希夫曼的观点,抗体水平高达250 - 300 ng抗体氮/毫升具有保护作用。一项针对老年人进行的现场试验显示对病死率有显著影响。由于局部抗原 - 抗体结合可能导致局部反应,4 - 5年内不应重复接种。